Recently opened studies

Below is a list of our lymphoma clinical trials opened within the last 3 months.

For all other open lymphoma clinical trials click here

 

 

Trial Name

 

Description

 

Click for further information (external page)

 

Date opened

 

C34004

 

Phase 2 Study of TAK-659 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Suitable for patients with lymphoma which has come back after previous treatment

 

More details

 

October 2017

 

 

JAVELIN DLBCL

 

A phase 1/3 trial testing a new drug avelumab.

Suitable for patients with lymphoma which has come back after previous treatment

 

More details

 

October 2017

 

 

PQR309-005

 

A phase 2 trial testing a targeted drug, PQR309.

Suitable for patients with CNS (brain) lymphoma which has come back after previous treatment

 

 More details

 

November 2017

 

 

INCYTE (CITADEL-202)

 

A phase 2 trial testing a new drug, INCB050465

Suitable for patients with Diffuse Large B cell lymphoma which has come back after previous treatment.

 

 More details

 

October 2017

 

 

This list is updated fortnightly. Click here to see all of our open clinical trials.

Last updated: September 2019